New Key Statistics Module, Z-Score and F-Score
DHA:ACIFORMULA Key Ratios
Market Cap BDT M | 6,090.52 |
Enterprise Value BDT M | 8,761.45 |
P/E(ttm) | 25.39 |
PE Ratio without NRI | 25.39 |
Forward PE Ratio | -- |
Price/Book | 2.02 |
Price/Sales | 1.25 |
Price/Free Cash Flow | 33.65 |
Price/Owner Earnings | 25.67 |
Payout Ratio % | 0.47 |
Revenue (TTM) BDT M | 5,049.00 |
EPS (TTM) BDT | 5.28 |
Beneish M-Score | -2.22 |
10-y EBITDA Growth Rate % | 7.50 |
5-y EBITDA Growth Rate % | 6.40 |
y-y EBITDA Growth Rate % | 22.30 |
EV-to-EBIT | 14.13 |
EV-to-EBITDA | 13.66 |
PEG | 3.97 |
Shares Outstanding M | 47.25 |
Net Margin (%) | 4.94 |
Operating Margin % | 10.76 |
Pre-tax Margin (%) | 6.51 |
Quick Ratio | 0.93 |
Current Ratio | 1.23 |
ROA % (ttm) | 3.50 |
ROE % (ttm) | 7.92 |
ROIC % (ttm) | 6.62 |
Dividend Yield % | 1.94 |
Altman Z-Score | 2.33 |
DHA:ACIFORMULA Number of Guru Trades
DHA:ACIFORMULA Volume of Guru Trades
Gurus Latest Trades with DHA:ACIFORMULA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:ACIFORMULA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data